PATH 6005 - Tumor Immunology & Immunotherapy

Immunotherapy has revolutionized cancer treatment over the past decade. Immunotherapy in cancer works by boosting a patient’s own immune system to fight their tumor. This course will cover basic principles in tumor immunology and will take a look at both approved and novel immunotherapies. Specific topics will include the roles of T cells and myeloid cells in tumor immunity, tumor neoantigens, immune checkpoint inhibitors (e.g., anti-CTLA-4 and anti-PD-1) as therapeutic agents, and cutting-edge areas of tumor immunology research. This course will primarily be a discussion-based class focused on current literature.